Outotec Receives Order for Two Alumina Calciners from Ma’aden

Outotec has received an order for two alumina calciners from Ma’aden Bauxite Alumina Company, a joint venture between Alcoa in Saudi Arabia and Saudi Arabian Mining Company.

The total worth of the order is about EUR 62 million. Outotec will deliver the equipment to Ma’aden’s integrated aluminum complex located in Ras Al Khair, Saudi Arabia.

Each calciner has the capacity to produce 3,500 tonnes of alumina every day. The company’s delivery comprises detail engineering and construction, civil work, design and process technology and spare parts for the equipment. The project will get completed by 2013 end.

The Chief Executive Officer of Outotec, Pertti Korhonen stated that the company’s calcination technology provides a number of benefits to Ma’aden. It consumes minimum energy and has very low emission levels. Other benefits include low lifetime expenses, high material recovery, reliable operation and use of raw materials in a sustainable manner.

Earlier, Outotec has designed and supplied the world’s biggest sulfuric acid complex to Ma’aden’s Ras Al Khair site. The company has a track record of delivering more than 50 alumina calciners across the globe.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Outotec Receives Order for Two Alumina Calciners from Ma’aden. AZoM. Retrieved on November 25, 2024 from https://www.azom.com/news.aspx?newsID=29931.

  • MLA

    Chai, Cameron. "Outotec Receives Order for Two Alumina Calciners from Ma’aden". AZoM. 25 November 2024. <https://www.azom.com/news.aspx?newsID=29931>.

  • Chicago

    Chai, Cameron. "Outotec Receives Order for Two Alumina Calciners from Ma’aden". AZoM. https://www.azom.com/news.aspx?newsID=29931. (accessed November 25, 2024).

  • Harvard

    Chai, Cameron. 2019. Outotec Receives Order for Two Alumina Calciners from Ma’aden. AZoM, viewed 25 November 2024, https://www.azom.com/news.aspx?newsID=29931.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.